' It's Going to Be a Useful Agent': Oxybutynin for Hot Flashes'It's Going to Be a Useful Agent': Oxybutynin for Hot Flashes

A urinary incontinence drug is surprisingly effective in the treatment of hot flashes for both women with a history of breast cancer and those with menopausal symptoms but who do not have cancer.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Related Links:

The women’s health technology or so-called femtech market has been on the rise for the last couple of years, but it has mainly revolved around fertility and pregnancy. We believe that female health topics reach far beyond such traditional issues and players should concentrate more on menopause, endometriosis, or mental health, just to name a few areas. Thus, we tried to collect companies which are on top of their game in the conventional fertility and/or pregnancy area, but also start-ups and ventures who are looking way beyond that. Here’s our guide to 10 outstanding companies in women’s health. The w...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Business Future of Medicine Health Sensors & Trackers Telemedicine & Smartphones companies company digital digital health digital health technologies femtech health technology Innovation market women women's health Source Type: blogs
We present a study protocol for a multicenter, prospective, non-inferiority, single-blinded, randomized controlled trial comparing the fractional microablative CO2 laser versus the photothermal non-ablative erbium:YAG laser for the management of GSM. We will recruit 88 postmenopausal women across two sites who will be randomized to one of the two laser groups. Participants will all have GSM symptoms and a Vaginal Health Index Score
Source: Climacteric - Category: Geriatrics Authors: Tags: Climacteric Source Type: research
Oxybutynin, a drug widely used to treat urinary incontinence caused by an overactive bladder, helps treat hot flashes in breast cancer survivors and women who did not have breast cancer but who were bothered by frequent or severe menopausal symptoms, new research shows.
Source: WebMD Health - Category: Consumer Health News Source Type: news
FRIDAY, Dec. 7, 2018 -- Hot flashes, a common curse in menopause, can be especially bothersome after breast cancer. But a new study suggests an existing medication may help. The drug is oxybutynin (Ditropan XL), long used to treat urinary...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
FRIDAY, Dec. 7, 2018 -- Hot flashes, a common curse in menopause, can be especially bothersome after breast cancer. But a new study suggests an existing medication may help. The drug is oxybutynin (Ditropan XL), long used to treat urinary...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
FRIDAY, Dec. 7, 2018 -- Hot flashes, a common curse in menopause, can be especially bothersome after breast cancer. But a new study suggests an existing medication may help. The drug is oxybutynin (Ditropan XL), long used to treat urinary...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Authors: Alexiades M Abstract Genitourinary syndrome of menopause (GSM), encompassing the disorders of atrophic vaginitis, urinary incontinence, and pelvic prolapse, affects the majority of postmenopausal women, as well as patients who are undergoing breast cancer treatement, post-ovarectomy, post-radiation, and breast-feeding. There is a need for better treatment options for these common conditions that adversely affect physical function and quality of life and that are often underserved by existing options. Lasers have been used to treat genitourinary tissue for over 40 years, and over the past decade, several la...
Source: Seminars in Cutaneous Medicine and Surgery - Category: Dermatology Tags: Semin Cutan Med Surg Source Type: research
 Back in February, MD+DI got the low down from an obstetrics and gynecologist specialist in Lubbock, TX on a new vaginal rejuvenation device that her patients have been raving about.  Now it seems the manufacturer of that particular device, along with other companies selling laser- or energy-based devices for vaginal rejuvenation failed to get FDA's blessing. "We've recently become aware of a growing number of manufacturers marketing 'vaginal rejuvenation' devices to women and claiming these procedures will treat conditions and symptoms related to menopause, urinary incontinence, or...
Source: MDDI - Category: Medical Devices Authors: Tags: Regulatory and Compliance Source Type: news
FDA head Dr. Scott Gottlieb today released a statement warning about “vaginal rejuvenation” procedures intended to treat conditions related to menopause, urinary incontinence or sexual function, saying that the products used in the procedures “don’t have adequate evidence to support their use for this purpose.” Gottliebb said that the procedures use lasers or energy-based devices to destroy or reshape vaginal tissue, and while the FDA has approved such devices for treating serious conditions such as the destruction of abnormal or precancerous cervical or vaginal tissues, the devices and proced...
Source: Mass Device - Category: Medical Devices Authors: Tags: Food & Drug Administration (FDA) Women's Health Alma Lasers Cynosure Inc. InMode Aesthetic Solutions sciton Source Type: news
Conclusion: Breast cancer survivors often experience GSM due to lack of estrogen. The worrisome lack of documentation of assessment or treatment for GSM in a large breast cancer survivorship practice reveals missed opportunities to improve quality of life. Dissemination of recent progress in the development of GSM assessment tools, patient handouts, and new treatments to providers who care for breast cancer survivors is needed to improve this process.
Source: Menopause - Category: OBGYN Tags: Original Articles Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Health | Hematology | Incontinence | Men | Menopause | Oxybutynin | Women